Belmont’s acquisition of MTRE extends its portfolio to include non-invasive body temperature management solutions and advances Belmont’s strategy to invest in technologies that leverage the company’s existing product portfolio and sales channels.

Brian Ellacott, Chief Executive Officer, Belmont, stated, “We are very pleased to bring the MTRE patient temperature management portfolio to healthcare providers worldwide and to the Belmont family. This is the first among several planned strategic acquisitions for Belmont as we build out a strong global product portfolio to better support clinicians and leverage our core strengths in anesthesiology, critical care and trauma.”

For more information: